Lundbeck to present new patient data on neuroendocrine and neuroimmunology programs at ENDO 2026

Upcoming presentations at ENDO 2026 highlight Lundbeck's Focused Innovator strategy and continued expansion into rare neuroendocrine diseases with high unmet medical needs The scientific program showcases Lundbeck's investigational neurohormonal and neuroimmunological targeted therapeutic...